Abu Dhabi Investment Authority
Abu Dhabi Investment Authority is an investment management agency investing funds on behalf of the Government of Abu Dhabi.
Business Model:
Revenue: $158M
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Abu Dhabi Investment Authority Information
Geographic Data
Address: 211 Corniche, PO Box 3600
City: Abu Dhabi
State: abu dhabi emirate
Zip:
Country: AE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Abu Dhabi Investment Authority is an investment management agency investing funds on behalf of the Government of Abu Dhabi. ADIA does not seek to manage or take an operational role in the companies in which it invests.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2022 | Acrisure | Private Equity Round | 0 |
| 5/2021 | Dedalus Group | Secondary Market | - |
| 10/2021 | GoTo Group | Private Equity Round | 0 |
| 10/2022 | Gravita India Ltd | Post-IPO Secondary | 2.2M |
| 5/2021 | Constellation Automotive Group | Private Equity Round | 1.4B |
| 10/2022 | Intas Pharmaceuticals | Secondary Market | - |
| 7/2022 | TMF Group | Secondary Market | - |
| 1/2022 | Eikon Therapeutics | Series B | 0 |
| 6/2020 | Reliance Jio | Private Equity Round | 752.6M |
| 8/2022 | Taibang Bio | Venture Round | 0 |
| 6/2022 | IIFL Finance | Post-IPO Equity | 282.7M |
| 3/2018 | Bandhan Bank | Private Equity Round | 206.4M |
| 6/2018 | Greenko Group | Private Equity Round | 450M |
| 8/2019 | Greenko Group | Debt Financing | 350M |
| 12/2015 | Alkem Laboratories | Venture Round | 0 |
| 11/2021 | Generate Biomedicines | Series B | 0 |
| 7/2019 | Greenko Group | Private Equity Round | 329M |
| 5/2021 | Charter Next Generation | Private Equity Round | - |
| 6/2019 | Greenko Group | Private Equity Round | 495M |
| 12/2021 | Sempra Infrastructure | Secondary Market | 1.8B |
| 1/2022 | DealShare | Series E | 0 |
| 1/2023 | Outrider | Series C | 0 |
| 7/2021 | Alight Solutions | Post-IPO Equity | 0 |
| 12/2021 | The Ardonagh Group | Private Equity Round | 0 |
| 5/2019 | MEGVII | Series D | 0 |
| 12/2014 | Virgin Voyages | Private Equity Round | 700M |
| 12/2022 | Craftsman Automation | Post-IPO Secondary | - |
| 12/2021 | The CrownX | Private Equity Round | 0 |
| 8/2022 | Aditya Birla Health Insurance | Secondary Market | 83.5M |
| 6/2018 | Pension Insurance | Private Equity Round | - |
| 11/2007 | Citi | Post-IPO Equity | 7.5B |
| 6/2016 | Greenko Group | Private Equity Round | 230M |
| 8/2022 | Taibang Biological Group | Private Equity Round | 300M |
| 12/2021 | SellerX | Venture Round | 499.7M |
| 12/2021 | Indiabulls Housing Finance | Post-IPO Secondary | 0 |
| 2/2018 | Moderna Therapeutics | Series G | 0 |
| 4/2022 | Tessera Therapeutics | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 10/2022 | Gokaldas Exports Ltd. | Post-IPO Equity | 6.4M |
| 12/2021 | Tata Digital | Post-IPO Equity | 50M |
| 1/2018 | Amber Group | Private Equity Round | 0 |
| 7/2019 | Domestic &a; General | Private Equity Round | - |
| 7/2019 | ReNew Power | Funding Round | 300M |
| 2/2020 | Okadoc | Series A | 10M |
| 10/2020 | Reliance Retail | Private Equity Round | 748.8M |
| 2/2023 | Syngene | Post-IPO Equity | 144.9M |
| 6/2022 | IIFL Home Loan | Private Equity Round | 282.7M |
| 8/2022 | Taibang Biological Group | Venture Round | 0 |
| 6/2021 | MobiKwik | Series G | 20.4M |
| 10/2015 | ReNew Power | Private Equity Round | 0 |
| 6/2020 | Fidelis Insurance | Equity | 500M |
| 4/2022 | HDFC Capital Advisors | Secondary Market | 24.1M |
| 7/2018 | Gossamer Bio | Series B | 0 |
| 10/2017 | Reliance Nippon Life Asset Management | Private Equity Round | 0 |
| 6/2018 | Kaleido | Series C | 101M |
| 8/2022 | Taibang Bio | Venture Round | 0 |
| 7/2022 | TMF Group | Secondary Market | - |
| 6/2022 | IIFL Home Loan | Private Equity Round | 0 |
| 5/2022 | Acrisure | Private Equity Round | 0 |
| 4/2022 | HDFC Capital Advisors | Secondary Market | 0 |
| 4/2022 | Tessera Therapeutics | Series C | 0 |
| 1/2022 | DealShare | Series E | 0 |
| 1/2022 | Eikon Therapeutics | Series B | 0 |
| 12/2021 | Sempra Infrastructure | Secondary Market | 0 |
| 12/2021 | Indiabulls Housing Finance | Post-IPO Secondary | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
